KALVISTA PHARMACEUTICALS LIMITED
Get an alert when KALVISTA PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£83m
highest in 3 filed years
Net assets
-£14m
Equity attributable
Employees
68
highest in 3 filed years
Profit before tax
£18m
Period ending 2025-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
-
Negative shareholders' funds
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-04-30 | 2025-04-30 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | £64,134,556 | — | |
| Operating profit | -£67,819,741 | -£63,203,011 | £26,037,851 | — | |
| Profit before tax | -£67,695,110 | -£61,066,694 | £17,847,553 | — | |
| Net profit | -£60,965,848 | -£61,696,872 | £14,812,242 | — | |
| Cash | £9,921,199 | £61,152,922 | £82,519,957 | — | |
| Total assets less current liabilities | -£994,004 | £46,565,907 | £98,864,788 | — | |
| Net assets | -£994,004 | -£30,808,971 | -£14,172,379 | — | |
| Equity | -£994,004 | -£30,808,971 | -£14,172,379 | — | |
| Average employees | 59 | 61 | 68 | — | |
| Wages | £6,254,057 | £7,346,280 | £5,713,046 | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing covers about 8 months versus 12 months prior. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-04-30 | 2025-04-30 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | — | — | 40.6% | |
| Net margin | — | — | 23.1% | |
| Return on capital employed | — | -135.7% | 26.3% | |
| Gearing (liabilities / total assets) | 104.7% | 140.4% | 112.1% | |
| Current ratio | 0.89x | 2.53x | 6.40x | |
| Interest cover | — | -35.70x | 2.52x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- KALVISTA PHARMACEUTICALS LIMITED 2011-05-06 → present
- KALVISTA LIMITED 2011-04-28 → 2011-05-06
- NEWINCCO 1089 LIMITED 2011-02-25 → 2011-04-28
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors recognise that, notwithstanding the profit reported for the current period, the Company continues to require investment to support the commercialisation of its ongoing research and development activities.”
Significant events
- “On 11 June 2026, the Chiesi Group completed its acquisition of KalVista Pharmaceuticals, Inc., the Company's ultimate parent undertaking at the reporting date, for cash consideration of US$27.00 per share.”
- “Following the completion of the Chiesi Group's acquisition of KalVista Pharmaceuticals, Inc., DRI Healthcare exercised its contractual put option in respect of its royalty participation right in EKTERLY. On 11 August 2026, approximately US$178 million was paid to DRI Healthcare in full settlement of the obligation.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LOVELL, Laura Amy | Secretary | 2026-06-11 | — | — |
| CANTONETTI, Monica | Director | 2026-06-11 | Oct 1968 | American |
| DICKINSON, Andrew Philip | Director | 2026-06-11 | Dec 1970 | British |
| IOTTI, Giorgio | Director | 2026-06-11 | Jun 1978 | Italian |
| ISAACS, Lawrence Mark | Director | 2026-06-11 | May 1968 | British |
| LOVELL, Laura Amy | Director | 2026-06-11 | Jan 1981 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DONNELLY, Stephen Gerard | Secretary | 2011-05-23 | 2024-11-27 |
| CSC CLS (UK) LIMITED | Corporate Secretary | 2026-01-28 | 2026-06-11 |
| OLSWANG COSEC LIMITED | Corporate Secretary | 2011-02-25 | 2011-05-23 |
| ALDRICH, Richard | Director | 2015-06-29 | 2016-12-06 |
| BINGHAM, Catherine Elizabeth, Dame | Director | 2015-11-11 | 2016-06-27 |
| BOULNOIS, Graham | Director | 2011-05-23 | 2015-11-11 |
| CROCKETT, Thomas Andrew | Director | 2011-05-23 | 2024-03-07 |
| EDWARDS, Martin William | Director | 2011-05-23 | 2016-12-06 |
| MACKIE, Christopher Alan | Director | 2011-02-25 | 2011-05-23 |
| PALLEIKO, Ben | Director | 2016-12-08 | 2026-06-11 |
| PIEKOS, Brian | Director | 2024-11-27 | 2026-06-11 |
| RESNICK, Joshua Benjamin, Dr | Director | 2016-06-27 | 2016-12-06 |
| SHAH, Rajeev | Director | 2015-06-29 | 2016-12-06 |
| OLSWANG DIRECTORS 1 LIMITED | Corporate Director | 2011-02-25 | 2011-05-23 |
| OLSWANG DIRECTORS 2 LIMITED | Corporate Director | 2011-02-25 | 2011-05-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Alberto Chiesi | Individual | Shares 25–50%, Voting 25–50% | 2026-06-22 | Active |
| Ms Maria Paola Chiesi | Individual | Significant influence | 2026-06-22 | Active |
| Mr Alessandro Chiesi | Individual | Significant influence | 2026-06-22 | Active |
| Mr Andrea Chiesi | Individual | Significant influence | 2026-06-22 | Active |
| Mr Giacomo Chiesi | Individual | Significant influence | 2026-06-22 | Active |
| Kalvista Pharmaceuticals Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-11-21 | Active |
Filing timeline
Last 20 of 114 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-06 | AA | accounts | Accounts with accounts type full | |
| 2026-07-15 | AP03 | officers | Appoint person secretary company with name date | |
| 2026-07-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-07-09 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-07-09 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-07-09 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-07-09 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-07-09 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-06-24 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-18 | TM01 | officers | Termination director company with name termination date | |
| 2026-06-18 | TM01 | officers | Termination director company with name termination date | |
| 2026-06-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-17 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-05-09 | AA | accounts | Accounts with accounts type full | |
| 2026-04-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-02-26 | CH01 | officers | Change person director company with change date | |
| 2026-02-25 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 20
- Capital events
- 0
- Officers appointed
- 6
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.